400 related articles for article (PubMed ID: 16916639)
21. Catalytic activity of caspase-3 is required for its degradation: stabilization of the active complex by synthetic inhibitors.
Tawa P; Hell K; Giroux A; Grimm E; Han Y; Nicholson DW; Xanthoudakis S
Cell Death Differ; 2004 Apr; 11(4):439-47. PubMed ID: 14713960
[TBL] [Abstract][Full Text] [Related]
22. Modulation of caspase activation by Toxoplasma gondii.
Hippe D; Gais A; Gross U; Lüder CG
Methods Mol Biol; 2009; 470():275-88. PubMed ID: 19089389
[TBL] [Abstract][Full Text] [Related]
23. Caspase-3 is required in the apoptotic disintegration of the nuclear matrix.
Kivinen K; Kallajoki M; Taimen P
Exp Cell Res; 2005 Nov; 311(1):62-73. PubMed ID: 16199031
[TBL] [Abstract][Full Text] [Related]
24. Caspase-dependant activation of chymotrypsin-like proteases mediates nuclear events during Jurkat T cell apoptosis.
O'Connell AR; Lee BW; Stenson-Cox C
Biochem Biophys Res Commun; 2006 Jun; 345(2):608-16. PubMed ID: 16690028
[TBL] [Abstract][Full Text] [Related]
25. The apoptotic effects of oxidative stress and antiapoptotic effects of caspase inhibitors on rat notochordal cells.
Kim KW; Ha KY; Lee JS; Rhyu KW; An HS; Woo YK
Spine (Phila Pa 1976); 2007 Oct; 32(22):2443-8. PubMed ID: 18090083
[TBL] [Abstract][Full Text] [Related]
26. Caspase-9 is the upstream caspase activated by 8-methoxypsoralen and ultraviolet-A radiation treatment of Jurkat T leukemia cells and normal T lymphocytes.
Martelli AM; Cappellini A; Tazzari PL; Billi AM; Tassi C; Ricci F; Falà F; Conte R
Haematologica; 2004 Apr; 89(4):471-9. PubMed ID: 15075081
[TBL] [Abstract][Full Text] [Related]
27. Structure-based thermodynamic analysis of caspases reveals key residues for dimerization and activity.
Piana S; Sulpizi M; Rothlisberger U
Biochemistry; 2003 Jul; 42(29):8720-8. PubMed ID: 12873132
[TBL] [Abstract][Full Text] [Related]
28. Caspase inhibitors.
Ekert PG; Silke J; Vaux DL
Cell Death Differ; 1999 Nov; 6(11):1081-6. PubMed ID: 10578177
[TBL] [Abstract][Full Text] [Related]
29. Serine protease inhibitors N-alpha-tosyl-L-lysinyl-chloromethylketone (TLCK) and N-tosyl-L-phenylalaninyl-chloromethylketone (TPCK) are potent inhibitors of activated caspase proteases.
Frydrych I; Mlejnek P
J Cell Biochem; 2008 Apr; 103(5):1646-56. PubMed ID: 17879947
[TBL] [Abstract][Full Text] [Related]
30. Mammalian initiator apoptotic caspases.
Ho PK; Hawkins CJ
FEBS J; 2005 Nov; 272(21):5436-53. PubMed ID: 16262685
[TBL] [Abstract][Full Text] [Related]
31. Measurement of caspase activity in individual cells reveals differences in the kinetics of caspase activation between cells.
Morgan MJ; Thorburn A
Cell Death Differ; 2001 Jan; 8(1):38-43. PubMed ID: 11313701
[TBL] [Abstract][Full Text] [Related]
32. Relevance of caspase activity during apoptosis in pubertal rat spermatogenesis.
Codelia VA; Cisternas P; Moreno RD
Mol Reprod Dev; 2008 May; 75(5):881-9. PubMed ID: 17926353
[TBL] [Abstract][Full Text] [Related]
33. Specific proteolysis of the A-kinase-anchoring protein 149 at the Asp582 residue by caspases during apoptosis.
Yoo H; Cha HJ; Lee J; Yu EO; Bae S; Jung JH; Sohn I; Lee SJ; Yang KH; Woo SH; Seo SK; Park IC; Kim CS; Jin YW; Ahn SK
Oncol Rep; 2008 Jun; 19(6):1577-82. PubMed ID: 18497968
[TBL] [Abstract][Full Text] [Related]
34. Cytotoxicity of diacetoxyscirpenol is associated with apoptosis by activation of caspase-8 and interruption of cell cycle progression by down-regulation of cdk4 and cyclin B1 in human Jurkat T cells.
Jun DY; Kim JS; Park HS; Song WS; Bae YS; Kim YH
Toxicol Appl Pharmacol; 2007 Jul; 222(2):190-201. PubMed ID: 17559898
[TBL] [Abstract][Full Text] [Related]
35. Interaction with XIAP prevents full caspase-3/-7 activation in proliferating human T lymphocytes.
Paulsen M; Ussat S; Jakob M; Scherer G; Lepenies I; Schütze S; Kabelitz D; Adam-Klages S
Eur J Immunol; 2008 Jul; 38(7):1979-87. PubMed ID: 18521960
[TBL] [Abstract][Full Text] [Related]
36. Peltophorum dubium and soybean Kunitz-type trypsin inhibitors induce human Jurkat cell apoptosis.
Troncoso MF; Biron VA; Longhi SA; Retegui LA; Wolfenstein-Todel C
Int Immunopharmacol; 2007 May; 7(5):625-36. PubMed ID: 17386410
[TBL] [Abstract][Full Text] [Related]
37. Doxorubicin-induced activation of protein kinase D1 through caspase-mediated proteolytic cleavage: identification of two cleavage sites by microsequencing.
Vántus T; Vertommen D; Saelens X; Rykx A; De Kimpe L; Vancauwenbergh S; Mikhalap S; Waelkens E; Kéri G; Seufferlein T; Vandenabeele P; Rider MH; Vandenheede JR; Van Lint J
Cell Signal; 2004 Jun; 16(6):703-9. PubMed ID: 15093611
[TBL] [Abstract][Full Text] [Related]
38. Maintenance of caspase-3 proenzyme dormancy by an intrinsic "safety catch" regulatory tripeptide.
Roy S; Bayly CI; Gareau Y; Houtzager VM; Kargman S; Keen SL; Rowland K; Seiden IM; Thornberry NA; Nicholson DW
Proc Natl Acad Sci U S A; 2001 May; 98(11):6132-7. PubMed ID: 11353841
[TBL] [Abstract][Full Text] [Related]
39. Recombinant caspase-3 expressed in Pichia pastoris is fully activated and kinetically indistinguishable from the native enzyme.
Sun J; Bottomley SP; Kumar S; Bird PI
Biochem Biophys Res Commun; 1997 Sep; 238(3):920-4. PubMed ID: 9325193
[TBL] [Abstract][Full Text] [Related]
40. Caspase activation: revisiting the induced proximity model.
Shi Y
Cell; 2004 Jun; 117(7):855-8. PubMed ID: 15210107
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
